Denosumab Safety Assessment in Multiple Observational Databases
Last updated on July 2021Recruitment
- Recruitment Status
- Active, not recruiting
- Estimated Enrollment
- 575462
Summary
- Conditions
- Osteoporosis
- Type
- Observational
- Design
- Observational Model: OtherTime Perspective: Prospective
Participation Requirements
- Age
- Between 55 years and 99 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT02520362
- Collaborators
- Aarhus University Hospital
- Optum, Inc.
- University of Alabama at Birmingham
- Investigators
- Study Director: MD Amgen